Forte Biosciences, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

FBRX

organization

SIC: 2834

SEC Insider

$9.4M

272 transactions

Summary

Forte Biosciences, Inc. (FBRX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.6MSales: $4.5M26 insiders

Date	Insider	Type	Value
2026-04-01	Riley Antony A(CHIEF FINANCIAL OFFICER)	F	$3K
2026-04-01	Wagner Paul A.(SEE REMARKS)	F	$2K
2026-06-16	Riley Antony A(CHIEF FINANCIAL OFFICER)	A	$0
2026-06-16	Wagner Paul A.(SEE REMARKS)	A	$0
2026-05-29	GRYSKA DAVID W	A	$0
2026-05-29	VINCENT RICHARD G	A	$0
2026-05-29	Doberstein Stephen K	A	$0
2026-05-29	Kornfeld Steven	A	$0
2026-05-29	Brun Scott C.	A	$0
2026-05-29	Kapoor Shivpreet Singh	A	$0
2026-04-01	Riley Antony A(CHIEF FINANCIAL OFFICER)	M	$0
2026-04-01	Riley Antony A(CHIEF FINANCIAL OFFICER)	M	—
2026-04-01	Wagner Paul A.(SEE REMARKS)	M	$0
2026-04-01	Wagner Paul A.(SEE REMARKS)	M	—
2026-01-12	Riley Antony A(CHIEF FINANCIAL OFFICER)	A	$0
2026-01-12	Riley Antony A(CHIEF FINANCIAL OFFICER)	A	$0
2026-01-12	Wagner Paul A.(SEE REMARKS)	A	$0
2026-01-12	Wagner Paul A.(SEE REMARKS)	A	$0
2026-01-01	Riley Antony A(CHIEF FINANCIAL OFFICER)	M	$0
2026-01-01	Riley Antony A(CHIEF FINANCIAL OFFICER)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Forte Biosciences, Inc. — Contributions, Lobbying & Contracts | Poliscope